Haberer Registered Investment Advisor’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$65K Hold
1,000
0.04% 113
2014
Q4
$59K Hold
1,000
0.03% 129
2014
Q3
$51K Sell
1,000
-100
-9% -$5K 0.02% 149
2014
Q2
$53K Sell
1,100
-861
-44% -$42.4K 0.02% 148
2014
Q1
$102K Hold
1,961
0.05% 110
2013
Q4
$104K Sell
1,961
-500
-20% -$25.5K 0.04% 111
2013
Q3
$114K Sell
2,461
-2,939
-54% -$129K 0.04% 114
2013
Q2
$241K Buy
+5,400
New +$234K 0.07% 99

Other funds holding BMY

Haberer Registered Investment Advisor's BMY Position: Q1 2015 in Review

Haberer Registered Investment Advisor held its Bristol-Myers Squibb (BMY) position steady in Q1 2015 at 1,000 shares worth $65K. The position accounts for 0.04% of the portfolio, ranked #113.

Haberer Registered Investment Advisor first reported a position in BMY in Q2 2013 and has held it in 8 quarters since. The position peaked at $241K in Q2 2013. 1,448 funds tracked by Wall St. Rank hold BMY as of Q1 2015.

  • Haberer Registered Investment Advisor held 1,000 shares of Bristol-Myers Squibb worth $65K as of Q1 2015.
  • Haberer Registered Investment Advisor left its Bristol-Myers Squibb share count unchanged in Q1 2015.
  • Bristol-Myers Squibb made up 0.04% of Haberer Registered Investment Advisor's portfolio in Q1 2015, its #113 holding.
  • Haberer Registered Investment Advisor first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 8 quarters since.
  • Haberer Registered Investment Advisor's Bristol-Myers Squibb position peaked at $241K in Q2 2013.
  • 1,448 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2015.

Based on Haberer Registered Investment Advisor's 13F filing for Q1 2015, filed 8 Apr 2015.